Project Grant NU58DP007836
Award Date
9/30/24
Completion Date
9/29/27
Dollars Obligated
$750K
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.283
Assistance Type
Project Grant
Place of Performance
Georgia, USA
Similar Awards
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) provides $295,294 to Biotherapeutics, Inc. for the development of a novel first-in-class topical immunoregulatory therapeutic for the treatment of plaque psoriasis. The key objectives are to: 1) evaluate the permeability and long-term stability of the topical drug product formulation, 2) compare the...
This federal Cooperative Agreement award under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program, administered by the Centers for Disease Control and Prevention (CDC), provides $2,018,760.00 in funding to Health Research, Inc. for the period of September 30, 2024 to June 29, 2029. The primary products and services to be delivered through this award include research, intervention, and awareness initiatives related to chronic disease prevention and...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $286,510 Cooperative Agreement under the Blood Disorder Program: Prevention, Surveillance, and Research (CFDA 93.080) to the Center for Public Health Innovation, a woman-owned non-profit organization, for the Sickle Cell Data Collection Program - 2023. This 5-year project, beginning on September 30, 2023, aims to work with state health agencies and other partners to plan, develop, implement, coordinate, and evaluate programs and...
This $899,694 Cooperative Agreement award was issued by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) federal grant program. The award was granted to The Regents of the University of California, San Francisco (UCSF) to fund activities related to chronic disease prevention and management. The five-year project period runs from September 30, 2024 to September 29, 2029. As the recipient, UCSF will leverage...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to define the cellular and molecular pathways by which interleukin-17A (IL-17A) drives the pathogenesis of psoriatic arthritis. The $664,933 award to Beth Israel Deaconess Medical Center, Inc. will fund the development and use of a novel animal model to interrogate...
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $900,000 Cooperative Agreement under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program to the University of Massachusetts Medical School (UMass Medical). The award period is from September 30, 2024 to September 29, 2029. Under this Cooperative Agreement, UMass Medical will conduct research, implement evidence-based interventions, and develop public health...
This federal Project Grant award from the Centers for Disease Control and Prevention (CDC) under CFDA 93.283 - Centers for Disease Control and Prevention Investigations and Technical Assistance provides $750,000.00 to the American College of Chest Physicians to bridge gaps in idiopathic pulmonary fibrosis (IPF) awareness and education. The grant, which runs from September 30, 2024 to September 29, 2027, aims to support research, surveillance, and technical assistance to state/local health...
This $600,000 Cooperative Agreement awarded by the Centers for Disease Control and Prevention (CDC) under the CFDA 93.283 Centers for Disease Control and Prevention Investigations and Technical Assistance program supports the documentation of outcomes associated with persistent tic disorders (including Tourette Syndrome) in children, adolescents, and young adults through surveillance. The project, with a performance period from Sep 30, 2024 to Sep 29, 2029, will be conducted by the University of...
This $2,054,187 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) Investigations and Technical Assistance program (CFDA 93.283) aims to expand the reach, quality, and effectiveness of asthma control services in high-burden areas of California. The award will be provided to the California Department of Public Health (CDPH) from September 1, 2024 through August 31, 2028. The funding will support research, surveillance, epidemiological investigations, and...
This $735,460 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 Arthritis, Musculoskeletal and Skin Diseases Research supports research to investigate how decreases in anti-inflammatory IL-10-producing B regulatory cells and increases in pro-inflammatory IL-6-producing B effector cells promote T cell inflammation and the development of psoriatic arthritis (PsA). The research will be conducted by Vanderbilt University...